Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Frontiers in Cell and Developmental Biology
|
October 5, 2020
Chromatin and Transcriptional Response to Loss of TBX1 in Early Differentiation of Mouse Cells
Andrea Cirino, Ilaria Aurigemma, Monica Franzese, et al.
Bioinformatics (Oxford, England)
|
April 28, 2022
SpatialExperiment: infrastructure for spatially-resolved transcriptomics data in R using Bioconductor
Dario Righelli, Lukas M Weber, Helena L Crowell, et al.
Elife
|
April 12, 2019
Shank3 modulates sleep and expression of circadian transcription factors
Ashley M Ingiosi, Hannah Schoch, Taylor Wintler, et al.
Iscience
|
September 16, 2024
A global transcriptional atlas of the effect of acute sleep deprivation in the mouse frontal cortex
Kaitlyn Ford, Elena Zuin, Dario Righelli, et al.
Biorxiv : the Preprint Server for Biology
|
December 11, 2023
A Global Transcriptional Atlas of the Effect of Sleep Deprivation in the Mouse Frontal Cortex
Kaitlyn Ford, Elena Zuin, Dario Righelli, et al.
Plos Computational Biology
|
August 25, 2023
Curated single cell multimodal landmark datasets for R/Bioconductor
Kelly B Eckenrode, Dario Righelli, Marcel Ramos, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 8, 2025
Bioconductor's Computational Ecosystem for Genomic Data Science in Cancer
Marcel Ramos, Lori Shepherd, Nathan C Sheffield, et al.
Nature Communications
|
November 18, 2021
Single cell multi-omic analysis identifies a Tbx1-dependent multilineage primed population in murine cardiopharyngeal mesoderm
Hiroko Nomaru, Yang Liu, Christopher De Bono, et al.
Nature Communications
|
March 25, 2026
First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial
Angela Damato, Riziero Esposito Abate, Simona Tessitore, et al.
Journal for Immunotherapy of Cancer
|
March 5, 2022
In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies
Caterina Ieranò, Dario Righelli, Crescenzo D'Alterio, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Frontiers in Cell and Developmental Biology
|
October 5, 2020
Chromatin and Transcriptional Response to Loss of TBX1 in Early Differentiation of Mouse Cells
Andrea Cirino, Ilaria Aurigemma, Monica Franzese, et al.
Bioinformatics (Oxford, England)
|
April 28, 2022
SpatialExperiment: infrastructure for spatially-resolved transcriptomics data in R using Bioconductor
Dario Righelli, Lukas M Weber, Helena L Crowell, et al.
Elife
|
April 12, 2019
Shank3 modulates sleep and expression of circadian transcription factors
Ashley M Ingiosi, Hannah Schoch, Taylor Wintler, et al.
Iscience
|
September 16, 2024
A global transcriptional atlas of the effect of acute sleep deprivation in the mouse frontal cortex
Kaitlyn Ford, Elena Zuin, Dario Righelli, et al.
Biorxiv : the Preprint Server for Biology
|
December 11, 2023
A Global Transcriptional Atlas of the Effect of Sleep Deprivation in the Mouse Frontal Cortex
Kaitlyn Ford, Elena Zuin, Dario Righelli, et al.
Plos Computational Biology
|
August 25, 2023
Curated single cell multimodal landmark datasets for R/Bioconductor
Kelly B Eckenrode, Dario Righelli, Marcel Ramos, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 8, 2025
Bioconductor's Computational Ecosystem for Genomic Data Science in Cancer
Marcel Ramos, Lori Shepherd, Nathan C Sheffield, et al.
Nature Communications
|
November 18, 2021
Single cell multi-omic analysis identifies a Tbx1-dependent multilineage primed population in murine cardiopharyngeal mesoderm
Hiroko Nomaru, Yang Liu, Christopher De Bono, et al.
Nature Communications
|
March 25, 2026
First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial
Angela Damato, Riziero Esposito Abate, Simona Tessitore, et al.
Journal for Immunotherapy of Cancer
|
March 5, 2022
In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies
Caterina Ieranò, Dario Righelli, Crescenzo D'Alterio, et al.
Page
of 3